Article

Identification of a FLG-wide-type bladder cancer subtype with poor prognosis and prediction use in immune checkpoint

2021-11-01

Abstract excerpt

<h4>Background: </h4> Bladder cancer (BLCA) is one of most common urinary tract malignant tumor and immunotherapy have generated a great deal of interest in BLCA. Immune checkpoint blockade (ICB) therapy has significantly progressed the treatment of BLCA. Multiple studies have suggested that specific genetic mutations may serve as immune biomarkers for ICB therapy. Objective In this study, we aimed to investigate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4dd6c489-05b9-55f7-8a90-1b6e37411bb4
DOI: 10.21203/rs.3.rs-1014390/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of a FLG-wide-type bladder cancer subtype with poor prognosis and prediction use in immune checkpointDOI 10.21203/rs.3.rs-1014390/v1Read

Advances in immunotherapy for bladder cancer and clinical practice of next-generation sequencing.Semantic proximity Read

Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.Semantic proximity Read

Identification of Four Immune Subtypes in Bladder Cancer Based on Immune Gene SetsSemantic proximity Read

Identification of tumor antigens and immune subtypes of bladder cancer for mRNA vaccine developmentSemantic proximity Read

Single-cell and bulk RNA-sequence identiﬁed ﬁbroblasts signature and CD8 + T-cell - ﬁbroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine learning: bioinformatics multi-omics studySemantic proximity Read

The Immunogenomic Landscape of and Immune Cell Infiltration in Bladder CancerSemantic proximity Read

The Cancer Genome Atlas Project in Bladder Cancer.Semantic proximity Read

Identification of RB1 Gene as a Immune-Related Prognostic Signature Based on Tumor Mutation Burdens in Bladder CancerSemantic proximity Read

Identification of subgroups of bladder cancer based on immune gene signatureSemantic proximity Read

Genetic and Epigenetic Alterations in Bladder CancerSemantic proximity Read

Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in BLCASemantic proximity Read